Researchers found that previously-untreated patients (PUPs) had a significantly higher incidence of inhibitors when treated with recombinant factor VIII than those treated with plasma-derived factor VIII.
Abstracts are due by Monday, June 6, 2016.
Applications for this $1,000 grant award are due Thursday, June 30. Get yours in today!
John was not only our friend, but also the heart and soul of our voice to this community.
September educational workshop in Columbus, OH, will focus on the clinical care of patients with hemophilia and inhibitors.
Gene therapy trials in lab animals show significant increases in production of factor VIII and IX.
This chapter provides nurses with best practices to guarantee that a child’s physical and academic needs are being met at school.
We applaud all of our hard-working nurses during National Nurses Week, which begins Friday, May 6th.
Eligible candidates pursuing hemostasis and/or thrombosis research should apply now for two research-related awards.
Reserve your spot for NHF 2016 Provider Workshops Program, Highlighting Key Payer Issues and Recommended Solutions on July 23.
eNewsletter Sign Up
Steps for Living
Victory for Women
Donate Your Car